ROYAL BANK OF CANADA - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 27 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$23,000
+2200.0%
3,600
+1933.9%
0.00%
Q4 2022$1,000177
+2428.6%
0.00%
Q3 2022$0
-100.0%
7
-96.0%
0.00%
Q2 2022$1,000
-66.7%
174
-38.5%
0.00%
Q4 2021$3,000283
+3942.9%
0.00%
Q2 2021$07
-58.8%
0.00%
Q1 2021$0170.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 1,583,878$10,168,49712.88%
Redmond Asset Management, LLC 137,689$883,9630.29%
K.J. Harrison & Partners Inc 34,640$216,8910.04%
WASATCH ADVISORS LP 612,088$3,929,6050.02%
Concord Wealth Partners 15,275$98,0660.02%
Caption Management, LLC 100,000$642,0000.01%
Summit Trail Advisors, LLC 35,000$224,7000.01%
NATIXIS 90,250$579,4050.01%
TD Waterhouse Canada Inc. 12,050$90,3460.00%
SIMPLEX TRADING, LLC 39,521$2530.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders